Fellowship · Charleston, WV
Sponsored by Charleston Area Medical Center
Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.
Journal of clinical medicine · 2025 · 55 citations · Mark Ayoub, Harleen Chela, Nisar Amin, Roberta Hunter, Veysel Tahan, Ebubekir Daglilar
Hepatocellular Carcinoma: A Comprehensive Review.
Diseases (Basel, Switzerland) · 2025 · 45 citations · Nisar Amin, Nadeem Anwar
Scurvy: Rediscovering a Forgotten Disease.
Diseases (Basel, Switzerland) · 2023 · 51 citations · Harleen Chela, Ebubekir Daglilar
Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
International journal of cardiology · 2021 · 61 citations ·
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study.
Cancers · 2024 · 28 citations · Mark Ayoub, Harleen Chela, Ebubekir Daglilar
Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
Journal of viral hepatitis · 2024 · 21 citations · Ebubekir Daglilar, Omer Basar, Veysel Tahan
The Future of Patient Education: AI-Driven Guide for Type 2 Diabetes.
Cureus · 2023 · 20 citations · Muhammad Bashir
Safety of endoscopic retrograde cholangiopancreatography (ERCP) in cirrhosis compared to non-cirrhosis and effect of Child-Pugh score on post-ERCP complications: a systematic review and meta-analysis.
Clinical endoscopy · 2023 · 15 citations · Ebubekir Daglilar